0001062993-23-003807.txt : 20230216 0001062993-23-003807.hdr.sgml : 20230216 20230216171716 ACCESSION NUMBER: 0001062993-23-003807 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlong Stephen CENTRAL INDEX KEY: 0001783360 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38546 FILM NUMBER: 23639381 MAIL ADDRESS: STREET 1: C/O NEURONETICS, INC. STREET 2: 3222 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neuronetics, Inc. CENTRAL INDEX KEY: 0001227636 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3222 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 877-600-7555 MAIL ADDRESS: STREET 1: 3222 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: NEURONETICS INC DATE OF NAME CHANGE: 20030416 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-02-14 0001227636 Neuronetics, Inc. STIM 0001783360 Furlong Stephen C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 0 1 0 0 CFO Common Stock 2023-02-14 4 S 0 12403 5.58 D 455282 D Common Stock 2023-02-15 4 S 0 13148 5.90 D 442134 D The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.41 to $5.72. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.81 to $6.00. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ W. Andrew Macan as Attorney-in-Fact 2023-02-16